Fidelity Investments
PDSB icon

Fidelity Investments’s PDS Biotechnology PDSB Stock Holding History

Fidelity Investments’s Portfolio PDSB Stock Details PDSB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-1,006
Closed -$1.02K – 5542
2025
Q3 		$1.02K Sell
1,006
-19
-2% -$22 ﹤0.01% 5015
2025
Q2 		$1.36K Sell
1,025
-1,753
-63% -$2.38K ﹤0.01% 4918
2025
Q1 		$3.31K Buy
2,778
+1,931
+228% +$2.75K ﹤0.01% 4799
2024
Q4 		$1.38K Sell
847
-1,362
-62% -$3.6K ﹤0.01% 4880
2024
Q3 		$8.44K Sell
2,209
-223
-9% -$744 ﹤0.01% 4481
2024
Q2 		$7.13K Buy
2,432
+1,068
+78% +$3.42K ﹤0.01% 4440
2024
Q1 		$5.4K Sell
1,364
-931
-41% -$4.8K ﹤0.01% 4479
2023
Q4 		$11.4K Buy
2,295
+779
+51% +$3.87K ﹤0.01% 4199
2023
Q3 		$7.65K Sell
1,516
-362
-19% -$1.98K ﹤0.01% 4206
2023
Q2 		$9.45K Buy
1,878
+1,863
+12,420% +$12.2K ﹤0.01% 4163
2023
Q1 		$92 Sell
15
-2
-12% -$16 ﹤0.01% 4912
2022
Q4 		$224 Buy
+17
New +$120 ﹤0.01% 4814
2021
Q3 		– Sell
-1
Closed – – 4852
2021
Q2 		$0 Buy
+1
New +$8 ﹤0.01% 4709
2018
Q1 		– Sell
-2,441
Closed -$457K – 2722
2017
Q4 		$457K Hold
2,441
– – ﹤0.01% 2536
2017
Q3 		$524K Sell
2,441
-60
-2% -$12.4K ﹤0.01% 2475
2017
Q2 		$513K Sell
2,501
-83
-3% -$16.4K ﹤0.01% 2504
2017
Q1 		$471K Sell
2,584
-7,870
-75% -$1.56M ﹤0.01% 2538
2016
Q4 		$2.61M Hold
10,454
– – ﹤0.01% 2327
2016
Q3 		$2.18M Hold
10,454
– – ﹤0.01% 2352
2016
Q2 		$2.11M Sell
10,454
-46,235
-82% -$8.17M ﹤0.01% 2374
2016
Q1 		$10.4M Sell
56,689
-88,446
-61% -$15.8M ﹤0.01% 1945
2015
Q4 		$36.3M Buy
+145,135
New +$46.8M ﹤0.01% 1391

Other funds holding PDSB

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
IWA
Inspirion Wealth Advisors Libertyville, Illinois $874M AUM 16.23% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Fidelity Investments's PDSB Position: Q4 2025 in Review

Fidelity Investments sold out of PDS Biotechnology (PDSB) in Q4 2025, closing a stake of 1,006 shares — an estimated $1.02K sold.

Fidelity Investments first reported a position in PDSB in Q4 2015 and held it in 22 quarters. The position peaked at $36.3M in Q4 2015. 44 funds tracked by Wall St. Rank hold PDSB as of Q4 2025.

  • Fidelity Investments reported no remaining PDS Biotechnology position as of Q4 2025 after selling out during the quarter.
  • Fidelity Investments sold 1,006 PDS Biotechnology shares in Q4 2025, an estimated $1.02K.
  • Fidelity Investments first reported a position in PDS Biotechnology in Q4 2015 and held it in 22 quarters.
  • Fidelity Investments's PDS Biotechnology position peaked at $36.3M in Q4 2015.
  • 44 funds tracked by Wall St. Rank held PDS Biotechnology as of Q4 2025.

Based on Fidelity Investments's 13F filing for Q4 2025, filed 17 Feb 2026.